Kinderaerztliche Gemeinschaftspraxis Wolfsburg
- Address
- lock Available on a paid plan
Diseases [C] - Skin and Connective Tissue Diseases [C17]
At the Kinderaerztliche Gemeinschaftspraxis Wolfsburg, research focuses on preventing atopic dermatitis in infants who have a strong family history of the condition. The study evaluates whether regular use of a moisturizing skin cream can reduce disease onset during the first six months of life.
- Prevention strategies for high‑risk infants
- Assessment of moisturizers on skin barrier function
- Early identification of atopic dermatitis signs
With two investigators overseeing the trial, the site contributes valuable data on childhood skin health, supporting families and clinicians in early intervention.
Diseases [C] - Bacterial Infections and Mycoses [C01]
The practice also conducts a vaccine study aimed at confirming the immunogenicity and safety of a conjugate vaccine against meningococcal groups A, C, W and Y in healthy infants and toddlers. The trial compares antibody responses with an established product to ensure comparable protection.
- Evaluation of meningococcal vaccine response in early childhood
- Comparison of new conjugate vaccine with existing standard
- Monitoring safety and seroresponse in infants and toddlers
Through this work, the Wolfsburg practice helps safeguard children against serious bacterial infections while collaborating with vaccine manufacturers and public health agencies.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Kinderaerztliche Gemeinschaftspraxis Wolfsburg
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Paraffin White Soft Cream for Prophylaxis of Atopic Dermatitis in High-Risk Pediatric Populations: A Randomized, Investigator-Blinded Study | INFECTOPHARM Arzneimittel und Consilium GmbH | Phase III | Not Recruiting | Jan 2020 | — |
IMP list
lock Showing 1 of 6 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| N. Meningitidis Group C (Strain C11) Polysaccharide (De-O-Acetylated) Conjugated To Tetanus Toxoid | 1 | Unknown | 2024-03-12 | 2024-03-12 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.